Clinical Evidence on Cannabinoids in PTSD and Substance Use
Cannabinoids and PTSD clinical evidence indicate that trauma-focused treatments benefit patients with co-occurring substance use disorders. Cannabis use does not diminish the effectiveness of evidence-based PTSD care. Clinicians should consider this…
Cannabinoid Clinical Trials: Full-Spectrum Cannabis for Back Pain
This phase 3 trial evaluated the full-spectrum cannabis extract for chronic low back pain in 820 adults. The study showed pain reduction and sustained benefits over 12 months. Full-spectrum cannabis extract offers a promising option for patients with…
Research on Cannabis Use and Behavioral Outcomes in Children with ASD
Peripregnancy cannabis exposure behavioral outcomes show varied effects on children with and without ASD symptoms. This research highlights differences in behavioral and developmental associations. Understanding these outcomes is crucial for counseling…
Cannabinoid Clinical Trials: Teen Cannabis Intervention Study
This study evaluates a rebuttal-based social norms-tailored cannabis intervention designed to improve prevention messaging for at-risk adolescents. Personalized approaches challenge negative reactions to standard cannabis messages. Findings support…
Endocannabinoid System Research: Cannabis in HIV Care
Digital therapeutics HIV smoking cessation research shows strong feasibility and acceptability among people living with HIV. This approach offers scalable cessation tools for this high-risk population. Tobacco use remains a leading cause of illness and…
Cannabidiol for Lennox-Gastaut: Cannabinoid Clinical Trials
Clinically meaningful reduction in drop seizures has been observed in Lennox-Gastaut syndrome patients treated with cannabidiol. Clinical trials show that even reductions below 50% can improve patient quality of life. Caregiver-reported outcomes align…
Cannabinoid Clinical Trials: CBD Gel Safety in Fragile X
Transdermal cannabidiol gel fragile x syndrome safety data comes from ongoing clinical trials evaluating long-term tolerability in children and adolescents. This synthetic CBD formulation targets behavioral symptoms linked to endocannabinoid…
Cannabinoid Clinical Trials: CBD, WADA, and Urine Testing Insights
Broad-spectrum CBD supplements doping risk is a critical concern for athletes subject to anti-doping rules. This study found that daily use of broad-spectrum CBD can produce detectable WADA-prohibited cannabinoids in urine. Exercise further amplifies…
Topical Cannabis for AIMSS: Cannabinoid Clinical Trials
Topical cannabis balms for AIMSS were tested in a randomized trial for breast cancer patients experiencing joint pain from aromatase inhibitor therapy. The study assessed feasibility and safety of cannabinoid topical treatments. Results provide early…
Cannabinoid Clinical Trials: Cannabis Effects on Alcohol Urge
Working memory cannabis alcohol urge interactions reveal how cognitive capacity affects alcohol cravings after cannabis use. This clinical trial shows that individuals with higher working memory capacity experience reduced alcohol urge. These findings…
